Inflammation Links Cardiac Injury and Renal Dysfunction: A Cardiovascular Magnetic Resonance Study

Overview

Journal Rev Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2024 Jul 30

PMID 39076541

Authors

Xiaohui Xie

Jiahong Chen

Lei Yu

Jianzhong Sun

Chengchen Zhao

Qingqing Duan

Affiliations

Soon will be listed here.

Abstract

Background: Inflammation is essential in cardiorenal syndrome, however there is still a lack of evidence proving the interaction between cardiac injury, renal dysfunction and the inflammatory response. This study aimed to illustrate the association between renal dysfunction and cardiac injury with a specific focus on the role of inflammation.

Methods: A single-center, retrospective study included patients with heart failure admitted to the cardiovascular department from September 2019 to April 2022. Patients received cardiovascular magnetic resonance (CMR) imaging (T1 mapping and late gadolinium enhancement (LGE)). Demographic, creatinine and native T1 were analyzed using pearson correlation, linear regression and adjusted for confounders. Interaction and subgroup analysis were performed.

Results: Finally, 50 validated heart failure (HF) patients (age 58.5 14.8 years; 78.0% men) were included. Cardiac global native T1 for the high estimated glomeruar filtration rate (eGFR) group was 1117.0 56.6 ms, and for the low eGFR group was 1096.5 61.8 ms. Univariate analysis identified global native T1 ( = 0.16, 95% confidence interval (CI): 0.04-0.28, = 0.014) and C-reactive protein (CRP) ( = 0.30, 95% CI: 0.15-0.45, 0.001) as determinants of creatinine. Multivariable linear regression analysis identified global native T1 ( = 0.12, 95% CI: 0.01-0.123, = 0.040) as a determinant of creatinine while age and diabetes were adjusted. Significant interactions between CRP and global native T1 in relation to creatinine level ( for interaction = 0.005) were identified.

Conclusions: Kidney dysfunction was associated with cardiac injury and inflammation, respectively. The interaction between myocardial injury and kidney dysfunction is contingent on the severity of the inflammatory response. Further studies were needed to identify the mechanisms of the inflammatory response in cardiorenal syndrome.

References

Messroghli D, Moon J, Ferreira V, Grosse-Wortmann L, He T, Kellman P . Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular.... J Cardiovasc Magn Reson. 2017; 19(1):75. PMC: 5633041. DOI: 10.1186/s12968-017-0389-8. View

Qin L, Gu S, Xiao R, Liu P, Yan F, Yu H . Value of native T1 mapping in the prediction of major adverse cardiovascular events in hemodialysis patients. Eur Radiol. 2022; 32(10):6878-6890. DOI: 10.1007/s00330-022-08839-8. View

Virzi G, Torregrossa R, Cruz D, Chionh C, De Cal M, Soni S . Cardiorenal Syndrome Type 1 May Be Immunologically Mediated: A Pilot Evaluation of Monocyte Apoptosis. Cardiorenal Med. 2012; 2(1):33-42. PMC: 3318942. DOI: 10.1159/000335499. View

Xu H, Yang Z, Zhang Y, Peng W, Xia C, Li Z . Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging. BMC Cardiovasc Disord. 2020; 20(1):12. PMC: 6954545. DOI: 10.1186/s12872-019-01313-2. View

Arcari L, Engel J, Freiwald T, Zhou H, Zainal H, Gawor M . Cardiac biomarkers in chronic kidney disease are independently associated with myocardial edema and diffuse fibrosis by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2021; 23(1):71. PMC: 8183054. DOI: 10.1186/s12968-021-00762-z. View

Hoffmann J, Shmeleva E, Boag S, Fiser K, Bagnall A, Murali S . Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patients. Circ Res. 2014; 116(1):87-98. PMC: 4280279. DOI: 10.1161/CIRCRESAHA.116.304393. View

Jankowski J, Floege J, Fliser D, Bohm M, Marx N . Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation. 2021; 143(11):1157-1172. PMC: 7969169. DOI: 10.1161/CIRCULATIONAHA.120.050686. View

Schefold J, Filippatos G, Hasenfuss G, Anker S, von Haehling S . Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol. 2016; 12(10):610-23. DOI: 10.1038/nrneph.2016.113. View

Kotanidis C, Bazmpani M, Haidich A, Karvounis C, Antoniades C, Karamitsos T . Diagnostic Accuracy of Cardiovascular Magnetic Resonance in Acute Myocarditis: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging. 2018; 11(11):1583-1590. DOI: 10.1016/j.jcmg.2017.12.008. View

10.

Abernethy A, Raza S, Sun J, Anstrom K, Tracy R, Steiner J . Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2018; 7(8). PMC: 6015440. DOI: 10.1161/JAHA.117.007385. View

11.

Pan J, Kerwin M, Salerno M . Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis. JACC Cardiovasc Imaging. 2020; 13(6):1299-1310. PMC: 7340140. DOI: 10.1016/j.jcmg.2020.03.010. View

12.

Takahashi H, Ishii H, Aoyama T, Kamoi D, Kasuga H, Ito Y . Association of cardiac valvular calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study. Am J Kidney Dis. 2012; 61(2):254-61. DOI: 10.1053/j.ajkd.2012.09.007. View

13.

Emrich T, Hahn F, Fleischmann D, Halfmann M, Duber C, Varga-Szemes A . T1 and T2 mapping to detect chronic inflammation in cardiac magnetic resonance imaging in heart failure with reduced ejection fraction. ESC Heart Fail. 2020; 7(5):2544-2552. PMC: 7524213. DOI: 10.1002/ehf2.12830. View

14.

Ahmed A, Rich M, Zile M, Sanders P, Patel K, Zhang Y . Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease. Am J Med. 2013; 126(2):150-61. PMC: 3575519. DOI: 10.1016/j.amjmed.2012.06.031. View

15.

Soriano S, Gonzalez L, Martin-Malo A, Rodriguez M, Aljama P . C-reactive protein and low albumin are predictors of morbidity and cardiovascular events in chronic kidney disease (CKD) 3-5 patients. Clin Nephrol. 2007; 67(6):352-7. DOI: 10.5414/cnp67352. View

16.

Hayer M, Radhakrishnan A, Price A, Liu B, Baig S, Weston C . Defining Myocardial Abnormalities Across the Stages of Chronic Kidney Disease: A Cardiac Magnetic Resonance Imaging Study. JACC Cardiovasc Imaging. 2020; 13(11):2357-2367. PMC: 7607516. DOI: 10.1016/j.jcmg.2020.04.021. View

17.

Rutherford E, Talle M, Mangion K, Bell E, Rauhalammi S, Roditi G . Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping. Kidney Int. 2016; 90(4):845-52. PMC: 5035134. DOI: 10.1016/j.kint.2016.06.014. View

18.

Everett B, Cornel J, Lainscak M, Anker S, Abbate A, Thuren T . Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure. Circulation. 2018; 139(10):1289-1299. DOI: 10.1161/CIRCULATIONAHA.118.038010. View

19.

Menon V, Greene T, Wang X, Pereira A, Marcovina S, Beck G . C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005; 68(2):766-72. DOI: 10.1111/j.1523-1755.2005.00455.x. View

20.

Patel R, Fonarow G, Greene S, Zhang S, Alhanti B, DeVore A . Kidney Function and Outcomes in Patients Hospitalized With Heart Failure. J Am Coll Cardiol. 2021; 78(4):330-343. PMC: 8994871. DOI: 10.1016/j.jacc.2021.05.002. View